Influence of Age on Susceptibility to Liver Carcinogenesis and Skin Initiating Action by Urethane in Swiss Mice

Por Chieco-Bianchi, L., De Benedictis, G., Tridente, G., Fiore-Donati, L.
Publicado em 1963

Brentuximab vedotin: axonal microtubule's Apollyon

Por Mariotto, S, Ferrari, S, Sorio, M, Benedetti, F, Tridente, G, Cavallaro, T, Gajofatto, A, Monaco, S
Publicado no Blood Cancer J (2015)

A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin

Por CASTELLETTI, D, FRACASSO, G, RIGHETTI, S, TRIDENTE, G, SCHNELL, R, ENGERT, A, COLOMBATTI, M
Publicado em 2004

Forecasting the growth of multicell tumour spheroids: implications for the dynamic growth of solid tumours

Por Chignola, R., Schenetti, A., Andrighetto, G., Chiesa, E., Foroni, R., Sartoris, S., Tridente, G., Liberati, D.
Publicado no Cell Prolif (2008)

Oscillating growth patterns of multicellular tumour spheroids

Por Chignola, R., Schenetti, A., Chiesa, E., Foroni, R., Sartpris, S., Brendolan, A., Tridente, G., Andrighetto, G., Liberati, D.
Publicado no Cell Prolif (2003)

Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin.

Por Chignola, R., Foroni, R., Franceschi, A., Pasti, M., Candiani, C., Anselmi, C., Fracasso, G., Tridente, G., Colombatti, M.
Publicado em 1995

Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones

Por Tommasi, M, Castelletti, D, Pasti, M, Fracasso, G, Lorenzetti, I, Sartoris, S, Pera, C, Ferrara, G B, Tridente, G, Colombatti, M
Publicado em 2001

Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies

Por Chignola, R, Cestari, T, Guerriero, C, Riviera, A P, Ferrari, S, Brendolan, A, Gobbo, M, Amato, S, Sartoris, S, Fracasso, G, Liuzzi, M G, Riccio, P, Tridente, G, Andrighetto, G
Publicado em 2000

Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness

Por Molderings, G. J., Dumoulin, F. L., Homann, J., Sido, B., Textor, J., Mücke, M., Qagish, G. J., Barion, R., Raithel, M., Klingmüller, D., Schäfer, V. S., Hertfelder, H. J., Berdel, D., Tridente, G., Weinstock, L. B., Afrin, L. B.
Publicado no Naunyn Schmiedebergs Arch Pharmacol (2020)